“…Other adverse factors are older age, adenocarcinoma, primary tumor stage-T3/4, poorly differentiated histology, extracapsular spread, incomplete resection and extent of resection (lobectomy vs. pneumonectomy) [7,[41][42][43]. Multilevel disease is associated with a uniformly poor prognosis in the order of 5 -15% five year survival and at this time surgery as the sole therapy is not recommended [44,45].…”